Literature DB >> 12651980

Danazol-induced hepatocellular carcinoma.

C Confavreux, P Sève, C Broussolle, P Renaudier, C Ducerf.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12651980     DOI: 10.1093/qjmed/hcg050

Source DB:  PubMed          Journal:  QJM        ISSN: 1460-2393


× No keyword cloud information.
  5 in total

1.  Danazol-Induced Hepatocellular Carcinoma in a Patient with Hereditary Angioedema.

Authors:  Muhammed Hameed Thoufeeq; Javaid Ishtiaq; Mohamed Abuzakouk
Journal:  J Gastrointest Cancer       Date:  2012-09

2.  Hepatocellular carcinoma in a noncirrhotic liver after long-term use of danazol for hereditary angioedema.

Authors:  Soraya Rahal; Marine Gilabert; Pauline Ries; Sandrine Oziel-Taieb; Slimane Dermeche; Jean-Luc Raoul
Journal:  Case Rep Oncol       Date:  2014-12-09

3.  Development of hepatocellular carcinoma after long-term immunosuppressive therapy including danazol in a dog.

Authors:  Kosuke Kobayashi; Takako Shimokawa Miyama; Kazuhito Itamoto; Shunsuke Noguchi; Kenji Baba; Takuya Mizuno; Masaru Okuda
Journal:  J Vet Med Sci       Date:  2016-06-20       Impact factor: 1.267

4.  Recent developments in the treatment of acute abdominal and facial attacks of hereditary angioedema: focus on human C1 esterase inhibitor.

Authors:  Lourdes Pastó Cardona; Ramon Lleonart Bellfill; Joaquim Marcoval Caus
Journal:  Appl Clin Genet       Date:  2010-12-03

5.  New treatments addressing the pathophysiology of hereditary angioedema.

Authors:  Alvin E Davis
Journal:  Clin Mol Allergy       Date:  2008-04-14
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.